Inhibition of nucleoside transport by protein kinase inhibitors.
about
Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.Nucleoside transporters in chronic lymphocytic leukaemia.Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.Nucleoside/nucleobase transporters: drug targets of the future?Physicochemical properties of novel protein kinase inhibitors in relation to their substrate specificity for drug transporters.Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors.Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase.Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products.Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.Raf-induced vascular endothelial growth factor augments Kaposi's sarcoma-associated herpesvirus infection.mTOR signaling regulates the processing of pre-rRNA in human cells.CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
P2860
Q30984991-C0D36675-3083-4FFA-87BF-73485D857788Q33624522-0E4D7941-2280-4B9F-A272-4AC77604275DQ35031403-0B1277C9-C14C-4190-9DDA-7A07C3CE48DCQ35567292-88D806DD-FD68-4C58-A8AC-B51349F58FF0Q35635321-1D98630A-93D0-4ACC-8D00-C49AF5973F7AQ35967219-C412010D-83FA-4724-887D-549C3A04BA8BQ36342657-C3DB17F3-F307-4B7A-9CF3-A1C61ED46E42Q36876245-9D31B748-B1B2-4A8E-9FD5-D4C6E455CC98Q37855808-40C8BBA9-B6E1-4130-97FF-7C86490C229BQ38336723-5B090B25-4075-4975-8FDE-1C8A2B9F5FEFQ38838740-8B616B96-83E6-47E6-B66A-EBF757F356A2Q39621896-9E42FDA7-B273-49CE-993E-45413EA6F4E0Q39791808-0E4E5EED-B8F2-4565-90FF-B2C07DB968FEQ39900095-A075B478-3367-457E-918E-58CE439587E1Q39965234-76DB8486-ACC7-4AF8-B336-C080D9CE87F9Q40012507-3DB6D0BE-CD6A-492D-9FCE-E3F27E3D645AQ40275471-25BBFCA3-20D2-4F82-AAE1-BB6CC022C2E1Q42562707-62EF3B55-A2CA-49A7-B651-F96F9725BA60Q45073108-6CFAE027-39BE-46B9-83E9-21073274174C
P2860
Inhibition of nucleoside transport by protein kinase inhibitors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inhibition of nucleoside transport by protein kinase inhibitors.
@en
Inhibition of nucleoside transport by protein kinase inhibitors.
@nl
type
label
Inhibition of nucleoside transport by protein kinase inhibitors.
@en
Inhibition of nucleoside transport by protein kinase inhibitors.
@nl
prefLabel
Inhibition of nucleoside transport by protein kinase inhibitors.
@en
Inhibition of nucleoside transport by protein kinase inhibitors.
@nl
P2093
P356
P1476
Inhibition of nucleoside transport by protein kinase inhibitors.
@en
P2093
Beverly S Mitchell
Lee M Graves
Susan B Cogut
Yanhong Wang
P304
P356
10.1124/JPET.102.044214
P407
P577
2003-02-01T00:00:00Z